A typical patient's first week in Sofia for stem cell knee therapy: arrival Monday, consultation and imaging Tuesday, bone marrow aspiration Wednesday, recovery Thursday–Sunday, departure Monday. Here's what to expect.
Elena arrives in Sofia on a Monday evening, having flown from London. She's 58, with moderate osteoarthritis in her right knee from a football injury 15 years ago. Walking more than two miles causes sharp pain; she's hoping stem cell therapy might avoid knee replacement. Her clinic—a private facility near the city centre—has arranged a hotel 10 minutes away via metro, cost included in her treatment package. She's nervous but forward-looking.
Tuesday morning, Elena attends her initial consultation. The physician, Dr. Petrov, reviews her medical history, examines her knee (range of motion, swelling, pain pattern), and shows her imaging from her GP: an MRI from three months prior showing cartilage thinning in the medial (inner) compartment, some osteophytes (bone spurs), but no bone-on-bone contact. He explains the plan: harvest bone marrow from her iliac crest (hip bone) on Wednesday, culture her mesenchymal stem cells for three weeks, then inject them into her knee joint four weeks from today. He's clear that improvement takes weeks, peaks at 3–6 months, and might include 40–50% pain reduction rather than complete resolution. She's relieved that he's realistic. That afternoon, she has baseline imaging: MRI of her knee (the clinic's radiologist will compare this to follow-up scans in 3, 6, and 12 months) and X-rays to rule out severe structural damage. The imaging room is modern; technicians speak English. Results are ready by evening.
Wednesday arrives. Elena fasts overnight (standard pre-procedure protocol). She's nervous about the bone marrow aspiration—she's read it can be painful—but the clinic has assured her that sedation is provided. She arrives early, signs consent forms, and sits in a clinical procedure room that looks like a private hospital space. An anaesthetist starts an IV and administers conscious sedation; Elena drifts into light sleep. Dr. Petrov uses a large needle to aspirate bone marrow from her hip; it takes 5 minutes. She feels pressure but no sharp pain thanks to the sedation. Afterwards, she returns to her hotel with a written protocol: ice the site, avoid heavy lifting, over-the-counter pain relief as needed. Her puncture site is sore but manageable with paracetamol.
Thursday through Sunday: Elena rests. The clinic's cell culture team begins isolating mesenchymal stem cells from her marrow sample and expanding them in a GMP-certified facility. Elena spends time exploring Sofia—it's a pleasant city with cheap cafes and parks—but keeps activity light to allow her hip to heal. She has a brief telehealth check-in Friday with the clinic's nurse coordinator, who confirms her pain level is normal and answers questions about the next three weeks. She attends a gym weakly on Friday and Saturday, avoiding impact. Sunday she packs and readies to depart Monday.
Four weeks later, Elena returns for her injection. She's apprehensive; three weeks of waiting has felt long. She has a pre-injection MRI to confirm her knee status hasn't changed, then Dr. Petrov injects approximately 50 million cultured autologous mesenchymal stem cells directly into her knee joint under ultrasound guidance. The injection takes 10 minutes; she feels pressure but not sharp pain. Afterwards, she's instructed to avoid heavy activity for two weeks, then gradually increase activity. She's given a detailed rehabilitation protocol: range-of-motion exercises starting day 3, light walking by week 2, normal activity by week 6. She's booked for imaging and clinical follow-up at her home hospital in the UK at 6 weeks, 3 months, and 6 months; results will be emailed to Dr. Petrov for review.
Over the next six months, Elena tracks her pain. Week 2: some improvement, but still substantial discomfort. Week 4: clearer improvement; she can walk a mile without significant pain. Week 8: walking two miles is now possible, though her knee isn't perfect. Month 4: pain continues to improve; she's off analgesics most days and enjoying normal activities. Six-month imaging shows cartilage thickness slightly improved (0.5 mm increase) and the area of concern looking slightly more robust. She's satisfied with the outcome—not a cure, but meaningful functional improvement—and attributes her success to matching expectations, following rehabilitation, and choosing a clinic with realistic counselling and rigorous follow-up.
Educational content; outcomes vary by patient and most uses are investigational — consult a physician. Reviewed by the StemCellAtlas editorial team.
GMP-zertifizierte regenerative Medizin mitten in der EU — ab 3.000–8.000 €, ein Bruchteil der US- oder Deutschland-Preise. Individuelle Protokolle für internationale Patienten aus über 50 Ländern.
Kostenlose ärztliche Prüfung